"Our study shows that COVID19 may precede GuillainBarré syndrome in rare cases, said Bart C Jacobs, one of the paper's authors, "but the existence of a true association or causal relation These permissions are granted for free by Elsevier for as long as the COVID19 resource centre remains active Abstract We report a case of GuillainBarré syndrome (GBS) following the first dose of Oxford/AstraZeneca COVID19 vaccine with papilledema as atypical onset As the COVID19 vaccination campaign progresses worldwide, GBSs vaccinerelated have However, whether COVID19 is another potential infectious trigger or whether the reported cases are coincidental is unclear "Our study shows that COVID19 may precede GuillainBarre syndrome in rare cases," said Bart C Jacobs, from Erasmus MC, University Medical Center Rotterdam, the Netherlands "But the existence of a true association or
Clinicians Urged To Spot Guillain Barre Syndrome After Covid 19 Vaccines
Guillain barre syndrome covid cases